MIT researcher Bob Langer and Harvard Medical School’s Jeff Karp say they have developed a drug that could address hearing loss by using chemical compounds to multiply and create new hair cells in the inner ear. Their company is called
Frequency Therapeutics. You can read their press release about the drug
here. Frequency Therapeutics published a research paper about their approach in the journal
Cell Reports. Read more about Frequency in
The Week. "Another Boston biotech," reports
Xconomy named "Decibel launched in October 2015 to develop drugs that combat some of the biological reasons for hearing issues."
